ABOUT  |  NEWS  |  PRODUCTS  |  TECHNOLOGY  |  INVESTOR RELATIONS  |  CAREER  |  PATIENTS

The Scientific Advisory Board


 

Prof. Dr. Burghardt Wittig, Germany

Chairman of the Scientific Advisory Board

Co-founder and former CEO of MOLOGEN AG

Professor for molecular biology and bioinformatics at the Freie Universität Berlin

 

Prof. em. Dr. Hans Lutz, FVH, FAMH, Switzerland

Vice Chairman of the Scientific Advisory Board

Professor for clinical laboratory diagnostics and head of the veterinary medicinal laboratory, Vetsuisse faculty, University of Zurich

 

Dr. Ulrich Granzer, Germany

Founder and CEO of Granzer Regulatory Consulting & Services, Munich

 

Dr. med. Stefan Manth, Switzerland

Independent expert for pharma and biotechnology

 

Dr. med. habil. Martin Weihrauch, Germany

Board certified Internist, Hematologist and Oncologist at the Center for Intergrated Oncology and Medical Director of the outpatient department (MVZ) at the University Clinic, Cologne

 

NEWS

Nov. 21, 2011

MOLOGEN attains the goals of the renal cancer study with MGN1601 ahead of schedule

 

 the press release

Nov. 18, 2011

MOLOGEN AG appoints Dr. Stefan M. Manth to the scientific advisory board


 the press release

NEWSLETTER

To receive our press releases please

 click here

REPORTS

To view our financial reports please

  click here